0 items USD 0.00Search
Your search for "Machine to Machine (M2M)" gave back 126 results.
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 225.00
CD123-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 225.00
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 225.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research鈥檚 latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report, "Innovation Tracking...
CBR Pharma Insights
June 2016
Price: USD 2,995.00
Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs Summary GBI Research's latest report, "...
CBR Pharma Insights
May 2016
Price: USD 2,995.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
颁补迟补濒辞驳:听
La Merie Publishing
June 2019
Price: USD 2,700.00
Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape Summary GBI Research's latest...
CBR Pharma Insights
March 2016
Price: USD 2,995.00
Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future Summary GBI Research鈥檚 latest report, "...
CBR Pharma Insights
December 2015
Price: USD 2,995.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research鈥檚 latest report, "Gene Therapies: A...
颁补迟补濒辞驳:听
CBR Pharma Insights
September 2015
Price: USD 2,995.00
鈥淣onalcoholic steatohepatitis (NASH) Pipeline Analysis鈥� gives comprehensive insight on the various drugs being developed for the treatment of NASH...
颁补迟补濒辞驳:听
IQ4I
July 2015
Price: USD 3,600.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
颁补迟补濒辞驳:听
La Merie Publishing
March 2015
Price: USD 2,183.00
The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development...
颁补迟补濒辞驳:听
La Merie Publishing
November 2014
Price: USD 499.00
The Competitive Intelligence Report Cardiometabolic Peptides as of November 2014 provides a competitor analysis in the development pipeline of...
颁补迟补濒辞驳:听
La Merie Publishing
November 2014
Price: USD 499.00
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis...
颁补迟补濒辞驳:听
La Merie Publishing
November 2014
Price: USD 381.00
听
